4 articles
Activist investor Ancora Holdings urges Ashland Inc., a specialty chemicals firm, to pursue a sale valued at $4.5 billion due to undervaluation. Potential buyers include Croda and Nouryon, while Ancor
Croda has opened a new greenfield manufacturing facility in Dahej, India, designed to meet growing demand in consumer care, life sciences, and industrial specialties sectors.
Croda reported lower earnings due to restructuring costs and impairments, while expecting organic sales growth this year.
Croda partners with a German firm to utilize precision amino acid manufacturing capabilities for pharmaceutical formulations and biomanufacturing. This collaboration aims to address customer demand ef
ChemBrief